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Abstract O-linked b-N-acetylglucosamine (O-GlcNAc) is an inducible, dynamically cycling and reversible posttranslational modification of Ser/Thr residues of nucleocytoplasmic and mitochondrial proteins. We recently discovered that O-GlcNAcylation confers cytoprotection in the heart via attenuating the formation of mitochondrial permeability transition pore (mPTP) and the subsequent loss of mitochondrial membrane potential. Because Ca 2? overload and reactive oxygen species (ROS) generation are prominent features of post-ischemic injury and favor mPTP formation, we ascertained whether O-GlcNAcylation mitigates mPTP formation via its effects on Ca 2? overload and ROS generation. Subjecting neonatal rat cardiac myocytes (NRCMs, n C 6 per group) to hypoxia, or mice (n C 4 per group) to myocardial ischemia reduced O-GlcNAcylation, which later increased during reoxygenation/reperfusion. NRCMs (n C 4 per group) infected with an adenovirus carrying nothing (control), adenoviral O-GlcNAc transferase (adds O-GlcNAc to proteins, AdOGT), adenoviral O-GlcNAcase (removes O-GlcNAc to proteins, AdOGA), vehicle or PUGNAc (blocks OGA; increases O-GlcNAc levels) were subjected to hypoxia-reoxygenation or H 2 O 2 , and changes in Ca 2? levels (via Fluo-4AM and Rhod-2AM), ROS (via DCF) and mPTP formation (via calceinMitoTracker Red colocalization) were assessed using time-lapse fluorescence microscopy. Both OGT and OGA overexpression did not significantly (P [ 0.05) alter baseline Ca 2? or ROS levels. However, AdOGT significantly (P \ 0.05) attenuated both hypoxia and oxidative stressinduced Ca 2? overload and ROS generation. Additionally, OGA inhibition mitigated both H 2 O 2 -induced Ca 2? overload and ROS generation. Although AdOGA exacerbated both hypoxia and H 2 O 2 -induced ROS generation, it had no effect on H 2 O 2 -induced Ca 2? overload. We conclude that inhibition of CaIntroduction Ischemia-reperfusion injury is one of the major causes of morbidity and mortality in the western world. Calcium overload, oxidative stress and the more recently implicated involvement of endoplasmic reticulum (ER) stress characterize pathologic components of ischemia-reperfusion injury. Additionally, ischemia-reperfusion injury also causes a wide variety of functional and structural changes to the mitochondria (Halestrap 2004a; Crompton 1999; Crow et al. 2004; Wang et al. 2005) , including activation of the mitochondrial death pathway. The mitochondrial death pathway culminates with the formation of the mitochondrial permeability transition pore (mPTP), which represents a non-specific pore spanning both the outer and inner mitochondrial membranes that allow molecules \1.5 kDa to enter and exit the mitochondrial matrix. mPTP is activated by calcium overload and reactive oxygen species (ROS), both of which are elevated in ischemia-reperfusion injury.
Manipulating the myocardium's response to ischemiareperfusion is known to delay and/or reduce myocardial injury. Indeed, most cardioprotective interventions are known to mediate cytoprotection in part via attenuation of mPTP formation. Protein phosphorylation/dephosphorylation is one of the most studied biochemical aspects associated with these cardioprotective interventions. Interestingly, the novel post-translational sugar modification, O-linked b-N-acetylglucosamine (O-GlcNAc), has been shown in numerous studies and in different cell types to act as an inducible, cytoprotective stress response (Zachara et al. 2004; Ngoh et al. 2010) . Our group (Ngoh et al. , 2009a Jones et al. 2008 ) and others (Champattanachai et al. 2007 (Champattanachai et al. , 2008 Yang et al. 2006; Zou et al. 2007 Zou et al. , 2009 ) have shown that enhanced O-GlcNAcylation of proteins attenuates cardiomyocyte death and reduces infarct size in mice. Moreover, recent data from our laboratory reveal that O-GlcNAcylation is cardioprotective by attenuating mPTP formation (Ngoh et al. , 2009a Jones et al. 2008 ) and the activation of the maladaptive arm of the unfolded protein response (Ngoh et al. 2009b) .
How O-GlcNAcylation mitigates mPTP formation is unknown. Therefore, we tested the hypothesis that O-GlcNAcylation reduces hypoxia-mediated mPTP formation via attenuating oxidative stress and Ca 2? overload in cardiomyocytes. We manipulated O-GlcNAc signaling and subjected myocytes to hypoxia-reoxygenation or oxidative stress to determine whether O-GlcNAcylation affected post-hypoxic or oxidative stress-induced ROS generation and Ca 2? overload. Our findings suggest that O-GlcNAcylation may attenuate mPTP formation by reducing Ca 2? overload and ROS generation.
Materials and methods

Murine in vivo ischemia-reperfusion
Three-month-old male C57BL6/J mice were subjected to in vivo coronary artery ischemia-reperfusion for assessment of O-GlcNAcylation levels according to a well-established protocol Palazzo et al. 1998a , b, Jones et al. 1999a , b, 2000 , 2001a , b, c, 2002 , b, 2004 Girod et al. 1999; Bueno et al. 2000; Hoffmeyer et al. 2000a, b; Condorelli et al. 2001; Scalia et al. 2001; Lefer et al. 2001; Sharp et al. 2002; Yang et al. 2003) . Mice were anesthetized with intraperitoneal injections of ketamine hydrochloride (50 mg/kg) and sodium pentobarbital (50 mg/kg). The animals were then attached to a surgical board with their ventral side up. The mice were orally intubated with polyethylene (PE)-60 tubing connected to a mouse ventilator (Harvard Apparatus), and the tidal volume and breathing rate set by standard allometric equations. The mice were supplemented with 100% oxygen via the ventilator side port. Body temperature was maintained between 36.5 and 37.5°C using an electrically controlled rectal probe and a heat lamp. A left thoracotomy was performed using a thermal cautery, and the proximal left coronary artery was visualized with the aid of a dissecting microscope and completely occluded for 40 min with 7-0 silk suture mounted on a tapered needle (BV-1, Ethicon). After 40 min, the suture was removed and reperfusion was initiated and visually confirmed. The chest was closed in layers using 4-0 silk suture. The skin was closed using 4-0 nylon suture. Ketoprofen was given as analgesia prior to closing the chest. Upon recovery of spontaneous breathing, mice were removed from the ventilator, extubated and allowed to recover in a warm, clean cage supplemented with 100% oxygen.
Myocardial ischemic/non-ischemic zone determination
Following the 40-min period of ligation of the left coronary artery in mice as described above, reperfusion was initiated. After 0, 1, 4 and 24 h of reperfusion, mice were anesthetized with isoflurane. A tracheotomy was performed and mice were ventilated as described above. A catheter (PE-10 tubing) was placed in the common carotid artery to allow for Evans blue dye injection. A median sternotomy was performed, and the left coronary artery was re-ligated in the same location as before. Evans blue dye (1.2 ml of a 2% solution) was injected into the carotid artery catheter into the heart to delineate the ischemic zone from the nonischemic zone. The heart was rapidly excised and serially sectioned along the long axis in 1-mm-thick sections. With the aid of a dissecting microscope, the non-ischemic and ischemic zones were separated and O-GlcNAcylation levels were assessed.
Neonatal rat cardiac myocyte isolation and culture Neonatal rat cardiac myocytes (NRCMs) were isolated from 1 to 2-day-old Sprague-Dawley rats and cultured according to an established protocol (Ngoh et al. , 2009a Teshima et al. 2003a, b; Akao et al. 2001; Jones et al. 2003c) . Cardiac myocytes in DMEM culture medium were plated on 35 mm glass bottom culture dishes at 75% density. During the first 4 days of culture, the medium contained the anti-mitotic BrdU (0.1 mmol/L) to inhibit any potential fibroblast growth in addition to 5% fetal bovine serum, penicillin/streptomycin and vitamin B 12 . At 24 h prior to experimentation, the medium was changed to serum-free DMEM. All experiments were performed on at least four separate NRCM cultures.
Gene transfer
NRCMs were infected for 48 h with 100 MOI of replication-deficient adenoviruses carrying either the rat O-GlcNAc transferase gene (AdOGT), the rat O-GlcNAcase gene (AdOGA) or the green fluorescent protein (AdGFP; Vector Biolabs), as described previously 2009a, b; Teshima et al. 2003b ). The medium was changed to serum-free DMEM and myocytes were subjected to hypoxia-reoxygenation or challenged with H 2 O 2 . Sample size was equal to at least four per group per treatment.
Enzyme inhibition
NRCMs were treated overnight with O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate (Ngoh et al. 2009a, b; Jones et al. 2008; Haltiwanger et al. 1998 
In vitro hypoxia-reoxygenation injury in cardiac myocytes
Untreated cardiac myocytes were subjected to 6 h of hypoxia in Esumi lethal media in humidified hypoxic chambers (Billups-Rothenberg Inc.) as previously described (Ngoh et al. , 2009b Kelly et al. 2003) . Following hypoxia, the media was changed to Esumi control media (Ngoh et al. , 2009a and culture dishes were reoxygenated for 0, 1 or 6 h in the modular incubator. Normoxic/aerobic controls were achieved by subjecting NRCMs to 6 h of normoxia and 6 h of reoxygenation in Esumi control media. Total cellular protein was isolated and immunoblotted for O-GlcNAc modification. Sample size was equal to six per group per treatment.
Induction of oxidative stress
Oxidative stress was induced in cultured NRCMs by adding 100 lmol/L H 2 O 2 , mixing and immediately imaging.
Protein expression
Total cellular proteins were isolated from NRCMs and heart sections, as previously described. As much as 50 lg of protein (according to Bradford assay) was applied to each lane of a 10% SDS-PAGE gel that was then electroblotted onto a PVDF membrane and probed for O-GlcNAc. A solution of 5% (v/v) reagent-grade non-fat milk in Trisbuffered saline was used for blocking, before incubating it in anti-O-GlcNAc antibody (1:1,000 CTD 110.6; Covance) overnight at 4°C. The blot was then incubated for 1 h with 0.05 lg/mL of goat anti-mouse IgM HRP-conjugated secondary antibody and detected with an enhanced chemiluminescent detection system (Pierce).
Enzymatic labeling of O-GlcNAc-modified proteins
O-GlcNAc-modified proteins were labeled using Invitrogen's Click-iT enzymatic labeling kit, as previously described . Briefly, detergents were precipitated out of 200 lg of whole cell lysate (n = 6 per group) using the chloroform/methanol precipitation method. The resulting pellets were then covered with lint-free paper and allowed to dry for 15 min in a fume hood. The dried pellets were resuspended in 40 lL of 1%, and allowed to cool on ice for 3 min. O-GlcNAc-modified proteins were then labeled with UDP-GalNAz (azide-modified UDP-N-acetylgalactosamine) using mutant b-1-4-galactosyltransferase at 4°C overnight. The next day, the GalNAz-labeled O-GlcNAcmodified protein mixture was precipitated using the chloroform/methanol precipitation method and resuspended in 50 lL of buffer containing 1% SDS and 50 mmol/L Tris-HCl (pH 8). The azide-labeled proteins were tagged with a fluorescent dye, TAMRA-alykne for 1 h at 4°C for the conversion of the azide group to a stable triazole conjugate. For 15 min, 25 mM DTT was added to stop the reaction and proteins were precipitated using the chloroform/methanol precipitation method. The dried, labeled protein sample was resuspended in SDS-PAGE buffer for electrophoresis. The gel was then imaged by excitation using a 532 nm laser on a TYPHOON 9400 imager.
Fluorescence microscopy
All fluorescent probes were purchased from Invitrogen. NRCMs were imaged in imaging/reoxygenation medium (DMEM with HEPES and minus phenol red and pyruvate). Images were captured using a Photometrics CoolSNAP ES camera attached to a Nikon-TE2000E2 fluorescence microscope with a T-PFS Perfect Focus Unit, all controlled with MetaMorph 6.3r2 software. The Perfect Focus System was used to prevent minute defocusing caused by changes over time during time-lapse imaging. Xcite 120 Fluor light source (level of 12%) was used and a Plan Apo 60xA/oil (NA = 1.4) objective was used for magnification. Neutral density filter setting was set at ND4 and binning of 29 for all image acquisition. Images were captured every 90 s for 60 min. Exposure duration, excitation filters and emission filters varied depending on the fluorescent dye, as mentioned below.
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5-(and-6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (DCF) fluorescence (Teshima et al. 2003b) . NRCMs were loaded with 2 lmol/L DCF for 30 min at 37°C and the medium was changed to imaging/reoxygenation medium. For certain normoxic NRCM cultures, oxidative stress was induced and imaging was initiated immediately by excitation of DCF through 470/40 nm bandpass filter and emission through 522/40 nm bandpass filters. Exposure duration was set at 100 ms and all experimental groups were repeated in at least four separate isolations.
Assessment of calcium overload
Intracellular calcium overload was assessed in NRCMs using time-lapse fluorescence microscopy by following the changes in rhod-2 (Ngoh et al. 2009a; Teshima et al. 2003b, c) and fluo-4 fluorescence ). For the hypoxia-reoxygenation study, NRCMs were loaded with 2 lmol/L rhod-2AM or 1 lmol/L fluo-4AM prior to hypoxia and imaging was initiated during reoxygenation. For oxidative stress studies, NRCMs were loaded with 1 lmol/L rhod-2AM (used to assess mitochondrial calcium) or 1 lmol/L fluo-4AM (used to assess cytosolic calcium) for 30 min at 37°C and the media was changed to imaging media. NRCMs were then treated with 100 lmol/ L H 2 O 2 and imaging was immediately initiated by sequentially exciting rhod-2 and fluo-4 through 560/28 and 470/40 nm bandpass filters, respectively. Emission was sequentially assessed through 646/38 nm (for rhod-2) and 522/40 nm (for fluo-4) bandpass filters. Exposure duration was set at 100 ms for both rhod-2 and fluo-4. All experimental groups were repeated in at least five separate NRCM cultures.
Assessment of mitochondrial permeability transition pore Formation of mPTP was assessed in NRCMs using timelapse fluorescence microscopy by following the changes in calcein fluorescence using a modified cold and warm loading protocol from Lemaster's group (Lemasters et al. 1998) . NRCMs were loaded with 0.5 lmol/L calcein-AM for 180 min at 4°C. Next, NRCMs were loaded with 1 lmol/L MitoTracker Red FM at 37°C for 60 min. NRCMs were then washed and oxidative stress induced with 50 or 100 lmol/L H 2 O 2 . Imaging was initiated immediately afterward by excitation of calcein through 470/40 nm bandpass filter and emission through 522/ 40 nm bandpass filter. Excitation for MitoTracker Red was through a 560/28 nm bandpass filter, while emission was through 646/38 nm bandpass filter. Exposure duration was set at 50 ms for calcein and 100 ms for MitoTracker Red. Mitochondrial calcein fluorescence was determined using MetaMorph software in regions where both MitoTracker Red and calcein fluorescence colocalized. Mitochondrial calcein localization was assessed by measuring the standard deviation (SD) of the intensity of all green fluorescent pixels within the same region of interest using MetaMorph software. Each given region of interest had several mitochondria, each undergoing mPTP at different times. The SD reflected how the calcein fluorescence intensity of each mitochondrion varied from the average fluorescent intensity for that region of interest. A region of interest was defined by drawing a circle (43.61 lm 2 ) enclosing several mitochondria. SD is high when fluorescence is punctate and low when fluorescence is diffuse. All experimental groups were repeated in at least five separate isolations.
Statistical analyses
Data were analyzed using one-way ANOVA and/or Dunnett's t tests using GraphPad Prism 4 software. Data are reported as mean ± standard error of the mean with differences between treatment groups accepted as significant when P \ 0.05.
Results
O-GlcNAc signaling changes during myocardial ischemia-reperfusion
We and others have shown that O-GlcNAcylation of proteins serves as an endogenously recruitable stress response (Ngoh et al. 2010) . Moreover, studies from Chatham's group show that in isolated perfused rat hearts, simulated ischemia augments O-GlcNAcylation (Fulop et al. 2007; Liu et al. 2007a, b) . Because nothing is known about in vivo changes in O-GlcNAcylation during myocardial ischemia-reperfusion injury, we directly addressed this question. We used the exogenous enzymatic labeling of O-GlcNAcylated proteins (click chemistry technique) to assess changes in O-GlcNAcylation levels in the ischemic (area at risk, n = 4 per group) and non-ischemic zones (n C 4 per group) of mice subjected to 40 min of myocardial ischemia (MI) via left coronary artery ligation or sham surgery and reperfused for 0 h (i.e., harvested after 40 min of ischemia without removing the ligature), 1, 4 or 24 h. Levels of O-GlcNAcylated proteins in the ischemic zone were reduced after 40 min of MI (group) compared to the sham group (Fig. 1b , P \ 0.05, representative images shown in a). After 1 h of reperfusion, O-GlcNAcylation levels in the ischemic zone were &1.6-fold higher than sham and dropped to baseline levels after 4 or 24 h of reperfusion (Fig. 1b) . Despite such changes in the ischemic zone of hearts from the MI group, there was no significant change in O-GlcNAcylated proteins in the non-ischemic (i.e., remote) zone from either MI or sham groups following ischemia or throughout reperfusion (Fig. 1c) . To correlate the level of O-GlcNAcylated proteins to the amount of damage suffered by the myocardium, plasma was harvested prior to killing in all groups. Using an ELISA-based technique, plasma levels of cardiac troponin-I (cTnI, an intracellular protein released from cardiomyocytes following damage or death) were measured (Fig. 1d) .
O-GlcNAcylation levels are altered following hypoxia-reoxygenation
To characterize the changes in O-GlcNAcylation during hypoxia and reoxygenation, we isolated NRCMs and subjected them to hypoxia and reoxygenation for 0, 1 or 6 h. Hypoxia significantly decreased O-GlcNAc levels compared to normoxia (Fig. 2a , P \ 0.05, representative images shown in b). Upon reoxygenation, we observed a time-dependent increase in O-GlcNAc levels peaking after 6 h (Fig. 2a , representative image shown in b) and falling by 18 h of reoxygenation (data not shown).
Hypoxia damaged cardiac myocytes, as reflected by an increase in post-hypoxic LDH release compared to normoxia. Reoxygenation further exacerbated hypoxia-mediated myocyte injury, mirrored by the time-dependent increase in post-hypoxic LDH release for hypoxic myocytes compared to normoxia (Fig. 2c) .
Manipulation of O-GlcNAc signaling alters oxidative stress ROS are important contributors to ischemia-reperfusion injury and interventions that prevent a rise in ROS generation reduce myocardial ischemia-reperfusion injury. Several studies have shown that the addition of antioxidants or ROS scavengers delay the onset or attenuate ischemia-reperfusion injury (Chi et al. 1989; Kilgore et al. 1994; Ambrosio et al. 1986 ). Therefore, we evaluated whether or not O-GlcNAc-mediated cardioprotection could be partially attributed to a reduction in oxidative stressmediated ROS generation. NRCMs were treated with an adenovirus carrying the null, OGT or OGA genes, or treated with vehicle or PUGNAc. NRCMs were then subjected to 3 h of hypoxia or oxidative stress induced with 100 lmol/L hydrogen peroxide (H 2 O 2 ). A change in DCF fluorescence during reoxygenation (or immediately following H 2 O 2 treatment) indicates changes in ROS levels. Hypoxia induced a significant (P \ 0.05) increase in ROS generation in NRCMs, reflected by increased DCF fluorescence (Fig. 3a) . This effect was significantly (P \ 0.05) attenuated by overexpression of OGT (Fig. 3a-c) or exacerbated by OGA overexpression. Additionally, inhibition of OGA with PUGNAc significantly reduced posthypoxic ROS production ( Fig. 3d-f) . Similarly, H 2 O 2 treatment induced significant ROS generation, which was mitigated by OGT overexpression and worsened by OGA overexpression according to DCF fluorescence ( Fig. 4a-c) . The protective effects of augmented O-GlcNAc signaling on ROS levels were also observed when O-GlcNAc signaling was increased via pharmacologic OGA inhibition using PUGNAc (Fig. 4d-f ). Despite the changes in ROS generation observed following hypoxia or peroxide treatment, there was no difference in ROS levels with either genetic (AdOGT or AdOGA) or pharmacologic (PUGNAc) manipulation of O-GlcNAc signaling during normoxia (data not shown).
Under normoxic conditions, basally generated ROS are efficiently detoxified by endogenous enzymatic antioxidants such as superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (Cat) (McCord 2000; Lucchesi et al. 1989 ). However, during ischemia-reperfusion injury, there is excess ROS generation such that ROS generated exceeds the capacity of endogenous oxidant defense mechanisms to detoxify ROS and hence leading to deleterious ROS-mediated reactions. Accordingly, we ascertained whether altered O-GlcNAcylation affected baseline expression of the antioxidant enzymes SOD, GPX and Cat. qRT-PCR for Cat, GPX, SOD1 and SOD2 mRNA levels was performed on normoxic NRCMs treated with AdGFP, AdOGA, Vehicle or PUGNAc. OGT overexpression (AdOGT) did not significantly alter (P [ 0.05) GPX, SOD1, SOD2, and Cat expression (Fig. 5a) . Overexpression of OGA (AdOGA) did not significantly change GPX, SOD1 or SOD2 expression, though Cat was significantly reduced (Fig. 5a , P \ 0.05). Likewise, inhibition of OGA with PUGNAc significantly increased Cat mRNA levels without changing SOD2 (Fig. 5b , P \ 0.05). (Murata et al. 2001; Girffiths and Halestrap 1995) . Moreover, dysregulation of mitochondrial Ca 2? is known to induce mPTP formation (Hunter and Haworth 1979; Crompton et al. 1987) . Accordingly, we assessed whether O-GlcNAcylation affects Ca 2? overload following hypoxia or oxidative stress in NRCMs (n C 6 per group). OGT overexpression did not alter baseline cytosolic or mitochondrial Ca 2? levels (data not shown), but significantly attenuated hypoxia-induced cytosolic (Fig. 6a-c) and mitochondrial (Fig. 6d-f ) Ca 2? overload according to fluo-4 and rhod-2 fluorescence, respectively. The protective effect of augmented O-GlcNAcylation on both posthypoxic cytosolic and mitochondrial Ca 2? overload was absent during the first 11 min of reoxygenation (Fig. 6c, f,  respectively) . Although fluo-4 and rhod-2 are generally accepted as cytosolic and mitochondrial calcium indicators (respectively), this is not a point of emphasis for the present study. Our point is to show two different indicators of intracellular calcium overload. Augmented OGT expression significantly attenuated H 2 O 2 -induced cytosolic (Fig. 7a-c) and mitochondrial (Fig. 8a-c) Ca 2? overload. Although OGA overexpression did not affect H 2 O 2 -induced cytosolic (Fig. 7a-c) or mitochondrial Ca 2? (Fig. 8a-c) , OGA inhibition with PUGNAc significantly reduced H 2 O 2 -induced cytosolic (Fig. 7d-f) and mitochondrial ( Fig. 8d-f overload, a lower concentration (50 lmol/L) of H 2 O 2 was used to induce oxidative stress. There was no difference in either cytosolic (Fig. 9a, c) or mitochondrial Ca 2? (Fig. 9b, c) overload induced by H 2 O 2 . Thus, the mechanism of exaggerated cell death in the context of elevated OGA activated may differ from loss of OGT activity (despite the fact that both treatments reduce O-GlcNAc levels).
O-GlcNAc signaling mitigates H 2 O 2 -induced mPTP formation
With mounting evidence suggesting that mPTP opening may be critical for the transition from reversible to irreversible myocardial ischemia-reperfusion injury (Crompton 1999), inhibition of mPTP formation likely represents an effective therapeutic approach in protecting the heart from reperfusion-induced damage. Indeed, direct and indirect inhibitors of mPTP opening have been shown to improve cardiac myocyte recovery after ischemia-reperfusion injury (Halestrap 2004b (Halestrap , 2006 . Therefore, we investigated whether manipulation of O-GlcNAc signaling affected oxidative stress-induced mPTP opening using calcein in NRCMs. Fluorescent calcein is concentrated in the mitochondrial matrix and can be used to detect mPTP opening (Bernardi et al. 1999) , as reflected by change from punctate to diffuse calcein fluorescence upon H 2 O 2 exposure, despite there being no change in MitoTracker red fluorescence (Fig. 10a-c) . H 2 O 2 mediated mPTP opening was significantly delayed and attenuated by OGT overexpression (Fig. 10a) , while OGA overexpression accelerated and worsened mPTP formation (Fig. 10a) compared to AdNull ? H 2 O 2 , though not significantly. Additionally, OGA inhibition (PUGNAc) significantly mitigated mPTP formation (Fig. 10d-f) and CsA, a known mPTP blocker, significantly inhibited H 2 O 2 -mediated mPTP opening (data not shown). overload and ROS generation.
In addition to its roles in signal transduction and in regulation of redox cell signaling, ROS generation contributes to myocardial ischemia-reperfusion injury . Enhanced O-GlcNAcylation of proteins (AdOGT and PUGNAc) mitigated both hypoxia-and oxidative stress-mediated ROS generation, while AdOGA exacerbated hypoxia-induced ROS generation. One might conjecture that O-GlcNAcylation attenuates ROS generation by upregulating the expression and/or activity of the antioxidant enzymes Cat, GPX and SOD. Moreover, forkhead box O1 (FoxO1), a regulator of the transcription of the oxidative stress responsive enzymes Cat and MnSOD (SOD2), was shown recently to be O-GlcNAc modified (Housley et al. 2009 ). O-GlcNAcylation of FoxO1 activates FoxO1 and can in turn lead to activation of transcription of oxidative stress response enzymes, Cat and MnSOD. Here, we show that neither augmented (AdOGT and PUGNAc) nor diminished (AdOGA) O-GlcNAcylation significantly altered baseline mRNA levels of SOD or GPX. However, inhibition of OGA (PUGNAc) augmented, while overexpression of OGA reduced, baseline Cat mRNA. The alteration in Cat expression with OGA manipulation partially explains the exacerbated post-hypoxic ROS generation seen with OGA overexpression and reduced ROS generation with OGA inhibition. Likewise, OGA inhibition reduced oxidant stress-induced ROS production but OGA overexpression surprisingly did not seem to have a negative effect in the same system. Another important finding in the present study is that enhanced O-GlcNAcylation attenuates post-hypoxic and oxidative stress-mediated Ca 2? overload. These data support previous findings by our group showing that augmented O-GlcNAcylation, via inhibition of OGA (PUGNAc), mitigated hypoxia-induced calcium overload, while reduction of O-GlcNAcylation, via OGA overexpression, worsened hypoxia-induced Ca 2? overload. Additionally, Nagy et al. (2006) previously showed that enhanced O-GlcNAcylation with glucosamine treatment blocked angiotensin II-induced cytosolic Ca 2? overload in neonatal cardiomyocytes and that such beneficial effects were dependent on OGT.
How O-GlcNAcylation attenuates Ca 2? overload in acute stress is unknown. Because a primary source for the rise in intracellular Ca 2? during/following ischemia or hypoxia might be via reverse functioning NCX, it is possible that enhanced O-GlcNAcylation levels mitigate cytosolic Ca 2? overload via indirect effects on an upstream activator of NCX or direct effect on NCX. Other possible mechanisms may be enhanced SERCA2a activity and/or decreased phospholamban binding to SERCA2a. Such hypotheses remain to be tested but are certainly worthy of investigation.
Enhanced O-GlcNAcylation also attenuates mitochondrial Ca 2? overload. Ca 2? likely enters the mitochondria via the mitochondrial uniporter. Because there may exist a mitochondrial OGT isoform (mOGT), which is thought to be membrane bound, it is possible that mOGT interacts with the mitochondrial Ca 2? uniporter preventing Ca 2?
uptake into the mitochondria. Therefore, understanding how O-GlcNAcylation affects Ca 2? handling in the heart is critical to the determination of how O-GlcNAcylation modulates mPTP. mPTP appears to be critical for the transition from reversible to irreversible myocardial ischemia-reperfusion injury (Crompton 1999) . ROS and Ca 2? activate mPTP and both of these are elevated during MI and reperfusion. Numerous cardioprotective pathways work primarily by inhibition of mPTP formation directly or indirectly by preventing the conditions that promote mPTP formation. The present study demonstrates that augmented O-GlcNAcylation (AdOGT or PUGNAc) attenuates mPTP formation in NRCMs, while diminished O-GlcNAcylation sensitizes NRCMs to mPTP formation. These data support previous findings by our group showing that enhanced O-GlcNAcylation reduces cardiac mitochondria to mPTP formation, while diminished O-GlcNAcylation sensitizes them to mPTP formation. Based on the present data, it is possible that one way through which O-GlcNAcylation mitigates mPTP formation might be through indirect means by attenuation of Ca 2? overload and ROS generation. In conclusion, it is abundantly clear that O-GlcNAcylation represents a significant mechanism in the heart's ability to successfully respond to a variety of stressors (Ngoh et al. 2010) . Future studies will identify calcium handling and mitochondrial proteins that are O-GlcNAcylated and attempt to elucidate how O-GlcNAcylation mitigates ROS and Ca 2? overload in acute MI.
